PTC Therapeutics
PTCT
#3023
Rank
HK$42.38 B
Marketcap
HK$511.17
Share price
-0.40%
Change (1 day)
62.25%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$42.38 Billion

As of May 2026 PTC Therapeutics has a market cap of HK$42.38 Billion. This makes PTC Therapeutics the world's 3023th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$42.38 B-13.64%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On May 4th, 2026 the market cap of PTC Therapeutics was reported to be:

HK$42.55 Billion
by Nasdaq info icon info icon
HK$42.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.181 T 5,047.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$836.39 B 1,873.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$7.64 B-81.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$18.09 B-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.94 B-95.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.15 B 108.00%๐Ÿ‡บ๐Ÿ‡ธ USA